Health Care Provision Worldwide

 

Some two billion of the more than seven billion people living on Earth do not have adequate basic health care. The growing world population – above all in developing countries and emerging markets – and demographic change in numerous industrialized nations are making it increasingly difficult to ensure adequate health care provision for the entire planet.

<strong>Family planning:</strong> Women in developing and emerging countries should be able to take control of their own lives. Working with partners, Bayer aims through the provision of more health information and education to reduce the risks associated with unplanned pregnancies and unsafe terminations.Zoom image
Family planning: Women in developing and emerging countries should be able to take control of their own lives. Working with partners, Bayer aims through the provision of more health information and education to reduce the risks associated with unplanned pregnancies and unsafe terminations.

Bayer is facing up to this challenge in keeping with its mission “Bayer: Science For A Better Life.” Thanks to our strategic commitment, the services of our health care business – high-quality drug products and treatments – are being made available to patients across the globe in countless programs.


The problem of inadequate health care in many countries will not be solved by individual companies and organizations acting alone, though, so a key focal point of our commitment is long-term cooperation with recognized aid organizations and international bodies.

Staying One Step ahead of Vector-borne Diseases (Zika, Malaria, Dengue)

Vector-borne diseases, like malaria, dengue, Chikungunya, Chagas or Zika, cause more than 1 million deaths annually; mosquitoes are responsible for transmitting the majority of those diseases, making them the deadliest animal on earth with 725,000 annual deaths attributed to its activities.

We leverage our history, expertise and innovation capacity to support vector-borne disease programs that protect and improve the quality of peoples’ lives. We focus on product development and advocacy partnerships and offer training and education initiatives to ensure the best and most sustainable outcome for public health and the environment.

Focus Issue Story: Living with Dengue

While dengue fever can affect all population groups and receives widespread attention, other tropical diseases plague the poorest of the poor in our world.


Find out how Bayer fights against neglected tropical diseases.

We understand our role to extend beyond providing innovative solutions.

We strongly support an integrated vector management approach

  • Awareness: Education and empowerment of local communities to become engaged in the fight can have a great impact: In urban environments the involvement of the community in reducing mosquito breeding sites and in personal protection measures is a key condition to break the infection cycle of vector-borne diseases.
  • Online learning: We offer an interactive online learning platform called Dengue Learning Lab, developed to address at-risk populations.
  • Partnerships: Since 2008 we have been co-developing new insecticides with the IVCC (International Vector Control Consortium) which are urgently needed for public health.
  • We are also working with organizations in endemic countries for results relevant to local conditions (e.g. IMR, Malaysia for PolyZone™ outdoor; Noguchi Institute, Ghana, and many more in Africa for Fludora™ Fusion).
  • Product Stewardship: We follow-up product supply with support and training in correct application of our products. For example, we support the Brazilian government in addressing the Zika emergency by training teams of local pest control operators in municipalities with high infestation together with an industry partner.
  • Collaboration: We collaborate with CDC (Center for Disease Control and Prevention) to provide products and training to government officials in Puerto Rico to help local communities in the fight against Zika.

Economic Strength also Means a Great Responsibility

We would like all people to share the fruits of medical progress, regardless of their origins or income. We support programs that provide access to innovative medicines and modern family planning, and take up the fight against neglected diseases. We work side-by-side with aid agencies, international bodies and policy makers.


Further information about our focus issues:

Last updated: December 22, 2016 Copyright © Bayer AG
http://www.bayer.com